Form 8-K - Current report:
SEC Accession No. 0001790340-25-000077
Filing Date
2025-06-17
Accepted
2025-06-17 06:09:26
Documents
12
Period of Report
2025-06-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K imrx-20250617.htm   iXBRL 8-K 26868
  Complete submission text file 0001790340-25-000077.txt   151266

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imrx-20250617.xsd EX-101.SCH 1807
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imrx-20250617_lab.xml EX-101.LAB 23705
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imrx-20250617_pre.xml EX-101.PRE 13601
14 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20250617_htm.xml XML 2922
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40675 | Film No.: 251051772
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)